Think Houston, think India, think biomedical innovation [Opinion]
Atul Varadhachary writes an opinion piece in the Houston Chronicle explaining why India must enact policy changes that reward investment in biopharmaceutical innovation:
India must expedite the implementation of formal policy changes, especially for regulatory and intellectual property protection reforms, that reward investment in biopharmaceutical innovation and drive economic growth. This will encourage allies to become partners in advancing health care in India. The country should also take a page from the Chinese pro-innovation playbook and leverage its consular network and vast diaspora to grow relationships and gain know-how from life sciences experts in the U.S. and around the world.
Read the entire article here.